PhaseBio Pharmaceuticals, Inc.
Q1 2019 13F Holders
Symbol
PHASQ
CUSIP
717224109
Type
Equity
Class
COM
Num filings
20
Total reported value, excl. options
$65.8 M
Compare 2019 Q1 to
2022 Q4
2022 Q3
2022 Q2
2022 Q1
2021 Q4
2021 Q3
2021 Q2
2021 Q1
2020 Q4
2020 Q3
2020 Q2
2020 Q1
2019 Q4
2019 Q3
2019 Q2
2018 Q4
Manager
Report Date
Value ($000)
Shares
Option Type